Stay updated on Pembrolizumab and Olaparib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Olaparib in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page history now includes a new revision tag, Revision: v3.5.4, replacing the previous Revision: v3.5.3. This reflects a minor update to the page's release version.
    Difference
    0.0%
    Check dated 2026-05-15T23:51:59.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The page’s displayed UI/release revision changes from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:11:49.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new revision v3.5.2 was added and the previous revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:31:35.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Added revision v3.5.0 to the record history and removed revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:52:43.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The version history now shows an addition of Revision: v3.4.3 and removal of Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:47:31.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Study Status updated to Completed on 2026-02-25 and Recruitment Status updated accordingly, replacing the previous Active, not recruiting status.
    Difference
    0.2%
    Check dated 2026-02-25T18:57:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Olaparib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Olaparib in NSCLC Clinical Trial page.